Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy.
作者： Nicolas Voirin , Christian Trépo , Jacques Estève , Philippe Chevallier , Jacques Ritter
DOI: 10.1097/00002030-200207260-00015
关键词: Cellular immunity 、 Immunology 、 Viral load 、 GB virus C 、 Hepatitis C virus 、 Lentivirus 、 Medicine 、 Virus 、 Acquired immunodeficiency syndrome (AIDS) 、 Viral disease 、 Virology
摘要: The effects of co-infection with hepatitis C virus (HCV) and GB (GBV-C) on CD4 cell counts plasma HIV-RNA levels has been investigated in HIV-infected patients treated highly active antiretroviral therapy (HAART). Patients co-infected HCV GBV-C experienced a increase during 4 years HAART, whereas the stopped after 2 other groups.
sci-hub.st 参考文章(10)
Andrew N. Phillips, Sophie Grabar, Jean-Michel Tassie, Dominique Costagliola, Jens D. Lundgren, Matthias Egger, Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS. ,vol. 13, pp. 2075- 2082 ,(1999) , 10.1097/00002030-199910220-00010
A. McNair, Janice Main, H. Thomas, Interactions of the human immunodeficiency virus and the hepatotropic viruses. Seminars in Liver Disease. ,vol. 12, pp. 188- 196 ,(1992) , 10.1055/S-2007-1007390
Jinhua Xiang, Sabina Wünschmann, Daniel J. Diekema, Donna Klinzman, Kevin D. Patrick, Sarah L. George, Jack T. Stapleton, Effect of coinfection with GB virus C on survival among patients with HIV infection. The New England Journal of Medicine. ,vol. 345, pp. 707- 714 ,(2001) , 10.1056/NEJMOA003364
Lionel Piroth, Michel Duong, Catherine Quantin, Michal Abrahamowicz, Renaud Michardiere, Ludwig-Serge Aho, Michèle Grappin, Marielle Buisson, Anne Waldner, Henri Portier, Pascal Chavanet, Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. ,vol. 12, pp. 381- 388 ,(1998) , 10.1097/00002030-199804000-00006
Hans L. Tillmann, Hans Heiken, Adriana Knapik-Botor, Stefan Heringlake, Johann Ockenga, Judith C. Wilber, Bernd Goergen, Jill Detmer, Martin McMorrow, Matthias Stoll, Reinhold E. Schmidt, Michael P. Manns, Infection with GB virus C and reduced mortality among HIV-infected patients. The New England Journal of Medicine. ,vol. 345, pp. 715- 724 ,(2001) , 10.1056/NEJMOA010398
Mina John, James Flexman, Martyn A.H. French, Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS. ,vol. 12, pp. 2289- 2293 ,(1998) , 10.1097/00002030-199817000-00010
D. Rey, S. Fraize, J. Vidinic, P. Meyer, S. Fritsch, N. Labouret, C. Schmitt, J.M. Lang, F. Stoll-Keller, High prevalence of GB virus c/hepatitis G virus RNA in patients infected with human immunodeficiency virus Journal of Medical Virology. ,vol. 57, pp. 75- 79 ,(1999) , 10.1002/(SICI)1096-9071(199901)57:1<75::AID-JMV11>3.0.CO;2-B
Eric S. Daar, Henry Lynn, Sharyne Donfield, Edward Gomperts, Stephen J. O'Brien, Margaret W. Hilgartner, W. Keith Hoots, David Chernoff, Steven Arkin, W.‐Y. Wong, Cheryl A. Winkler, , Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs The Journal of Infectious Diseases. ,vol. 183, pp. 589- 595 ,(2001) , 10.1086/318539
LM Jarvis, F Davidson, JP Hanley, PL Yap, CA Ludlam, P Simmonds, Infection with hepatitis G virus among recipients of plasma products The Lancet. ,vol. 348, pp. 1352- 1355 ,(1996) , 10.1016/S0140-6736(96)04041-X
G Greub, B Ledergerber, M Battegay, P Grob, L Perrin, H Furrer, P Burgisser, P Erb, K Boggian, J-C Piffaretti, B Hirschel, P Janin, P Francioli, M Flepp, A Telenti, Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. The Lancet. ,vol. 356, pp. 1800- 1805 ,(2000) , 10.1016/S0140-6736(00)03232-3